Ovid Therapeutics Inc.

OVID·NasdaqCM·Healthcare
Compare
2.7400+0.3400 (+14.17%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.4000
Open2.5000
Day range2.37502.7850
52-week range1.18003.1050
Off day high−1.62%
Off 52-week high−11.76%
Volume3.61M
Avg. volume (3M)1.70M
Market cap535.12M
EPS (TTM)-0.2200
Forward P/E-7.47
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.24
Shares outstanding195.30M
Short interest10.59% of float
Earnings dateAug 13, 2026 (est.)
Analyst target6.4000
Profit margin0.00%

Against its peers

Compare in full ›
OVID OCS ZVRA NP5.F PRAX VYGR
Market cap 535.12M 448.36M 663.32M 205.50M 7.95B 115.23M
P/E (TTM) — — 9.2 — — —
Forward P/E -7.5 -3.8 10.4 — -30.0 -1.5
Price/book 2.4 1.8 4.1 -17.9 5.9 0.7
Dividend yield — — — — — —
1-year change +80.45% −60.53% +1.89% −38.08% +70.38% −57.14%
Today +14.17% −4.59% +8.87% −0.50% +1.53% +2.19%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All OVID news ›

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance